PeiXi Chen

PeiXi Chen

Auto-generated profile, based on publicly available information

PeiXi Chen

Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2019 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MBMariana Bravo-Hernandez
Mariana Bravo-Hernandez
TTTakahiro Tadokoro
Takahiro Tadokoro
MNMichael R. Navarro
Michael R. Navarro
OPOleksandr Platoshyn
Oleksandr Platoshyn
YKYoshiomi Kobayashi
Yoshiomi Kobayashi
MMMartin Marsala
Martin Marsala

9 May 2018 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
JSJan Strnadel
Jan Strnadel
CCCassiano Carromeu
Cassiano Carromeu
CBCedric Bardy
Cedric Bardy
MNMichael Navarro
Michael Navarro
OPOleksandr Platoshyn
Oleksandr Platoshyn
MMMartin Marsala
Martin Marsala
Syngeneic iPSC–derived neurons survive and mature without immunosuppression after grafting into the spinal cord of adult pigs.

12 September 2016 in Chinese Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
SJShouzhen Jiang
Shouzhen Jiang
Hengwei QiuHengwei Qiu
Hengwei Qiu
SGSaisai Gao
Saisai Gao
PCPeixi Chen
Peixi Chen
ZLZhen Li
Zhen Li
SWShuyun Wang
Shuyun Wang

2 June 2026 in bioRxiv
Verified
Preprint
Open access
JKJonas Koeppel
Jonas Koeppel
AKAidan Keith
Aidan Keith
SSSamantha Sgrizzi
Samantha Sgrizzi
PCPeixi Chen
Peixi Chen
RDRiza M. Daza
Riza M. Daza
SPSudarshan Pinglay
Sudarshan Pinglay
What fraction of the human genome is essential for cellular viability? To date, essentiality in human cells has been mapped almost exclusively at the level of individual open reading frames (ORFs). Whether noncoding regions and broader architectural features of the genome are required for human cells to remain viable, and where the boundaries of any such regions lie, remains largely unexplored. Here we introduce Shred-seq, which couples Type I-C CRISPR-Cas3-mediated deletions with phage polymerase-based genotyping to enable large-scale deletion scans of the human genome. Shred-seq leverages thousands of genomically integrated, mapped target sites as launchpads for Cas3 to initiate unidirectional deletions ranging in size from hundreds of base pairs (bp) to hundreds of kb. Breakpoints are directly captured at high resolution by in vitro or in situ transcription from flanking phage polymerase promoters, enabling bulk or single-cell phenotyping, respectively. In this proof-of-concept, we generate and genotype 36,257 independent deletions originating from 9,604 Cas3 launchpads, individually spanning 100 bp to 500 kb, collectively covering 461 Mb (14% of the human genome), and totaling to 2.55 Gb of deleted sequence (∼10-fold coverage of these regions). Surviving deletions are depleted not only for essential protein-coding genes, but also for active, conserved and mutation-constrained non-coding sequences, directly quantifying purifying selection across both coding and noncoding intervals. Deletion length distributions further enable annotation-agnostic fine mapping of essential region boundaries and establish an empirical lower bound on the fraction of the human genome required for cellular viability. Finally, we demonstrate compatibility with single-cell RNA-seq (scRNA-seq), enabling direct linkage of specific deletions to transcriptional phenotypes. Together, Shred-seq provides a scalable platform for the systematic dissection of genome architecture and noncoding function, as well as for generating training data for predictive and generative models of genome structure-function, analogous to the roles that conventional Perturb-seq screens play for ORFs. By enabling the empirical delimitation of the genomic content required for human cellular viability, Shred-seq may also open a path to the construction of a minimal human genome.